Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Risk of meningioma and common variation in genes related to innate immunity.

Rajaraman P, Brenner AV, Neta G, Pfeiffer R, Wang SS, Yeager M, Thomas G, Fine HA, Linet MS, Rothman N, Chanock SJ, Inskip PD.

Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1356-61. doi: 10.1158/1055-9965.EPI-09-1151. Epub 2010 Apr 20.

2.

Common variation in genes related to innate immunity and risk of adult glioma.

Rajaraman P, Brenner AV, Butler MA, Wang SS, Pfeiffer RM, Ruder AM, Linet MS, Yeager M, Wang Z, Orr N, Fine HA, Kwon D, Thomas G, Rothman N, Inskip PD, Chanock SJ.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1651-8. doi: 10.1158/1055-9965.EPI-08-1041.

3.

DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma.

Rajaraman P, Hutchinson A, Wichner S, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Rothman N, Linet MS, Inskip PD.

Neuro Oncol. 2010 Jan;12(1):37-48. doi: 10.1093/neuonc/nop012. Epub 2009 Dec 10.

4.

Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk.

Shiels MS, Engels EA, Shi J, Landi MT, Albanes D, Chatterjee N, Chanock SJ, Caporaso NE, Chaturvedi AK.

Cancer. 2012 Nov 15;118(22):5630-6. doi: 10.1002/cncr.27605. Epub 2012 Oct 8.

5.

Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.

Sun J, Wiklund F, Zheng SL, Chang B, Bälter K, Li L, Johansson JE, Li G, Adami HO, Liu W, Tolin A, Turner AR, Meyers DA, Isaacs WB, Xu J, Grönberg H.

J Natl Cancer Inst. 2005 Apr 6;97(7):525-32.

PMID:
15812078
6.

XRCC1 and XRCC3 variants and risk of glioma and meningioma.

Kiuru A, Lindholm C, Heinävaara S, Ilus T, Jokinen P, Haapasalo H, Salminen T, Christensen HC, Feychting M, Johansen C, Lönn S, Malmer B, Schoemaker MJ, Swerdlow AJ, Auvinen A.

J Neurooncol. 2008 Jun;88(2):135-42. doi: 10.1007/s11060-008-9556-y.

PMID:
18330515
7.

Comprehensive analysis of DNA repair gene variants and risk of meningioma.

Bethke L, Murray A, Webb E, Schoemaker M, Muir K, McKinney P, Hepworth S, Dimitropoulou P, Lophatananon A, Feychting M, Lönn S, Ahlbom A, Malmer B, Henriksson R, Auvinen A, Kiuru A, Salminen T, Johansen C, Christensen HC, Kosteljanetz M, Swerdlow A, Houlston R.

J Natl Cancer Inst. 2008 Feb 20;100(4):270-6. doi: 10.1093/jnci/djn004. Epub 2008 Feb 12.

PMID:
18270339
8.

Association study on MTHFR polymorphisms and meningioma in northern China.

Li R, Wang R, Li Y, Li X, Feng Y, Li Y, Jiang C.

Gene. 2013 Mar 10;516(2):291-3. doi: 10.1016/j.gene.2012.12.019. Epub 2012 Dec 28.

PMID:
23276705
9.
10.

Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma.

Martínez C, Molina JA, Alonso-Navarro H, Jiménez-Jiménez FJ, Agúndez JA, García-Martín E.

BMC Neurol. 2010 Aug 19;10:71. doi: 10.1186/1471-2377-10-71.

11.

Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.

Hu W, Bassig BA, Xu J, Zheng T, Zhang Y, Berndt SI, Holford TR, Hosgood HD 3rd, Leaderer B, Yeager M, Menashe I, Boyle P, Zou K, Zhu Y, Chanock S, Lan Q, Rothman N.

Environ Mol Mutagen. 2013 Jan;54(1):72-7. doi: 10.1002/em.21739. Epub 2012 Oct 11.

PMID:
23055202
12.

Genetic polymorphisms in host innate immune sensor genes and the risk of nasopharyngeal carcinoma in North Africa.

Moumad K, Lascorz J, Bevier M, Khyatti M, Ennaji MM, Benider A, Huhn S, Lu S, Chouchane L, Corbex M, Hemminki K, Försti A.

G3 (Bethesda). 2013 Jun 21;3(6):971-7. doi: 10.1534/g3.112.005371.

13.

A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.

Hosgood HD 3rd, Purdue MP, Wang SS, Zheng T, Morton LM, Lan Q, Menashe I, Zhang Y, Cerhan JR, Grulich A, Cozen W, Yeager M, Holford TR, Vajdic CM, Davis S, Leaderer B, Kricker A, Schenk M, Zahm SH, Chatterjee N, Chanock SJ, Rothman N, Hartge P, Armstrong B.

Br J Haematol. 2011 Mar;152(6):721-6. doi: 10.1111/j.1365-2141.2010.08518.x. Epub 2011 Jan 20.

14.

Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma.

Malmer BS, Feychting M, Lönn S, Lindström S, Grönberg H, Ahlbom A, Schwartzbaum J, Auvinen A, Collatz-Christensen H, Johansen C, Kiuru A, Mudie N, Salminen T, Schoemaker MJ, Swerdlow AJ, Henriksson R.

J Neurooncol. 2007 May;82(3):229-37. Epub 2006 Dec 7.

PMID:
17151932
15.

Genotyping of patients with sporadic and radiation-associated meningiomas.

Sadetzki S, Flint-Richter P, Starinsky S, Novikov I, Lerman Y, Goldman B, Friedman E.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):969-76.

16.

p53 Genotypes and risk of glioma and meningioma.

Malmer B, Feychting M, Lönn S, Ahlbom A, Henriksson R.

Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2220-3.

17.

Meningioma: is there an association with human leukocyte antigens?

Machulla HK, Steinborn F, Tschigrjai M, Langner J, Rainov NG.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1438-42.

18.

Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma.

Bethke L, Webb E, Murray A, Schoemaker M, Feychting M, Lönn S, Ahlbom A, Malmer B, Henriksson R, Auvinen A, Kiuru A, Salminen T, Johansen C, Christensen HC, Muir K, McKinney P, Hepworth S, Dimitropoulou P, Lophatananon A, Swerdlow A, Houlston R.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1195-202. doi: 10.1158/1055-9965.EPI-07-2733.

19.

Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.

Chen YC, Giovannucci E, Kraft P, Lazarus R, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1982-9.

20.

Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer.

Ryan BM, Zanetti KA, Robles AI, Schetter AJ, Goodman J, Hayes RB, Huang WY, Gunter MJ, Yeager M, Burdette L, Berndt SI, Harris CC.

Int J Cancer. 2014 Mar 15;134(6):1399-407. doi: 10.1002/ijc.28457. Epub 2013 Nov 14.

Supplemental Content

Support Center